Bonus BioGroup Ltd. Logo

Bonus BioGroup Ltd.

Develops cell therapies and tissue products for bone grafts and inflammation repair.

BONS | TA

Overview

Corporate Details

ISIN(s):
IL0004850116
LEI:
Country:
Israel
Address:
Park P.O.B 15143, 31905 Haifa
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Bonus BioGroup Ltd. is a clinical-stage biotechnology company specializing in regenerative medicine. The company develops investigational cell therapy and tissue engineering products to address unmet medical needs related to tissue damage, inflammation, and bone loss. Its pipeline is led by two key candidates: BonoFill, a personalized, viable bone graft engineered from a patient's own cells for orthopedic and maxillofacial applications; and MesenCure, an allogeneic cell therapy designed to target inflammation and promote tissue repair. These therapies are currently being evaluated in clinical trials for safety and efficacy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-27 11:48
Investor Presentation
Company Presentation- 2025
Hebrew (modern) 9.0 MB
2025-05-27 11:48
Regulatory News Service
Company Presentation- 2025
Russian 43.6 KB
2023-07-11 12:06
Investor Presentation
Company Presentation, July 2023
English 3.4 MB
2023-07-11 12:06
Investor Presentation
Company Presentation, July 2023
Russian 44.7 KB
2022-04-11 16:02
Investor Presentation
Company Presentation
English 8.2 MB
2022-04-11 16:02
Registration Form
Company Presentation
Russian 47.1 KB
2022-04-11 15:01
Investor Presentation
Company Presentation
Hebrew (modern) 11.0 MB
2022-04-11 15:01
Pre-Annual General Meeting Information
Company Presentation
Russian 47.1 KB
2022-01-10 10:52
Regulatory News Service
The company inteds to publish an immediate report, trading will be open after …
Hebrew (modern) 105.1 KB

Automate Your Workflow. Get a real-time feed of all Bonus BioGroup Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonus BioGroup Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonus BioGroup Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Logo
Integrated media group providing data-driven advertising and media solutions for global brands.
Türkiye PCILT
Peers Co.,Ltd. Logo
Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.
Japan 7066
PeptiDream Inc. Logo
Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.
Japan 4587
PharmaLundensis AB Logo
Develops treatments for heavy metal toxicity and serious respiratory illnesses.
Sweden PHAL
Pharos iBio Co., Ltd. Logo
AI-powered drug development for rare and refractory diseases, focusing on oncology.
South Korea 388870
PhoenixBio Co.,Ltd. Logo
CRO providing humanized liver mouse models and testing services for preclinical drug development.
Japan 6190
P&K Skin Research Center Co.,Ltd. Logo
Clinical research for dermatological testing in cosmetics, pharma, and health food sectors.
South Korea 347740
Plantarc Bio Ltd. Logo
Developing high-yield, resilient crops via gene discovery for global seed companies.
Israel PLNT
Polymetal International plc Logo
A top global gold and silver producer with mining and exploration operations in Kazakhstan.
Kazakhstan POLY
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL

Talk to a Data Expert

Have a question? We'll get back to you promptly.